Amerigen develops generic versions of ‘niche’ pharmaceutical products which offer longer term profitable marketability.   As such, we are product opportunistic. Amerigen develops these products with the aim of being the first to file the generic form of the product.   Our primary market consideration for project viability has been our US generic market, however, we are now pursuing products for global markets.

愛美津開發仿制藥的小眾產品，以提供更長期的市場盈利。這也正是我們的產品機會。愛美津的目標即是開發首仿藥。我們的初期市場考慮是美國仿制藥市場的項目可行性。然而，我們現在則追求產品的全球市場。

At Amerigen, we are committed to developing, manufacturing and marketing high quality generic pharmaceuticals. We believe all patients taking our medications, wherever they are located, are entitled to the highest quality products.

我們的使命：致力優質藥物，福澤全球病患

Our vision is to be at the forefront of our industry in bringing complex oral generic products to patients in the markets we serve. Our target products are carefully selected to ensure our resources, expertise and energy are focused on the opportunities that can bring the most benefit to all our stakeholders. We then rely on great science and passionate execution to bring these opportunities to fruition.

我們的愿景：立足科技前沿，爭創行業先鋒，回報社會和股東